Thai Ho
Director of Precision Medicine, MUSC Hollings Cancer Center · Medical University of South Carolina College of Medicine
Credentials: · · · · · ·
History
PresentMUSC Hollings Cancer Center · Medical University of South Carolina College of Medicine
- 2006–2009
Internal Medicine
- 2002–2006
Research
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
New England Journal of Medicine · 2016 · 1,060 citations
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Science · 2018 · 999 citations
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Cell Reports · 2018 · 633 citations
- RJ
20 papers
- EC
18 papers
15 papers
14 papers
13 papers
11 papers
9 papers
8 papers · 4 as a fellow
Grants
- 2023–2028
Synthetic Lethal Targeting of SETD2 in Renal Cell Carcinoma
National Cancer Institute · R01
PI · $2.1M · Mayo Clinic Rochester
- 2018–2024
Deciphering the Interplay Between H3K36 and DNA Methylation in Renal Cancer
National Cancer Institute · R01
PI · $2.9M · Mayo Clinic Rochester
Clinical trials
- 2025–2037
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology